HomeNewsBusinessEconomyExclusive: Ola goes slow in credit-card lane as COVID-19 takes a toll on its core, cab aggregating business
Trending Topics

Exclusive: Ola goes slow in credit-card lane as COVID-19 takes a toll on its core, cab aggregating business

Customer acquisition for Ola Money SBI credit cards has slowed because of the pandemic. But, as market conditions improve, Ola is hoping to make a comeback

August 27, 2020 / 16:40 IST
Story continues below Advertisement
Ola
Ola

Cab aggregating major Ola is going slow on its credit business, which was designed to offer small-value loans and credit cards to consumers who use the platform for their daily commute, said two sources in the know of the matter.

Ola runs an expansive financial services programme from payments to lending through a separate entity, Ola Financial Services. It starts with ‘Ola Money Postpaid’, where users take rides and pay later. Some customers are also offered a larger credit line through the Ola Money app, and a credit card in partnership with SBI Cards.

Story continues below Advertisement

Sources said the company has currently taken its foot off the pedal for both the credit line and credit card programmes in terms of new customer acquisition. Reason: the slowdown in the overall travel business because of COVID-19.

The main objective of the co-branded credit card and the credit line was to acquire quality customers who used Ola services regularly. So, a regular Ola user could use Ola Money for in-ride payments as well as outside the Ola ecosystem.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show